PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'European Medicines Agency (EMA), Amsterdam, The Netherlands.\', \'Medical University of Vienna, Vienna, Austria.\', \'BfArM, Bonn, Germany.\', \'EMA\'s Committee for Medicinal Products for Human Use (CHMP), Amsterdam, The Netherlands.\', \'Universidade de Lisboa, Lisbon, Portugal.\', \'University Tor Vergata, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cpt.1891
?:doi
?:hasPublicationType
?:journal
  • Clinical pharmacology and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 32407539
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 169
?:title
  • Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32407539>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32407539>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all